Pfizer Inc. (PFE)

AI Score

Unlock

21.96

0.05 (0.23%)

At close: Apr 14, 2025, 1:53 PM

Pfizer Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	63.63B	58.5B	100.33B	81.29B	41.91B	51.75B	53.65B	52.55B	52.82B
Cost of Revenue	16.42B	29.69B	34.34B	30.82B	8.69B	10.22B	11.25B	11.24B	12.33B
Gross Profit	47.21B	28.81B	65.99B	50.47B	33.22B	41.53B	42.4B	41.31B	40.49B
Operating Income	14.94B	3.36B	40.03B	24.83B	10.63B	15.14B	15.04B	14.11B	13.73B
Interest Income	545M	1.62B	251M	36M	73M	226M	333M	391M	470M
Pretax Income	8.02B	1.06B	34.73B	24.31B	7.5B	17.68B	11.88B	12.3B	8.35B
Net Income	8.03B	2.12B	31.37B	21.98B	7.02B	16.27B	11.15B	21.31B	7.21B
Selling & General & Admin	14.73B	14.77B	13.68B	12.7B	11.62B	14.35B	14.46B	14.78B	14.84B
Research & Development	10.82B	10.68B	11.43B	13.83B	9.4B	8.65B	8.01B	7.66B	7.87B
Other Expenses	n/a	n/a	3.61B	3.7B	3.44B	4.61B	1.14B	981M	820M
Operating Expenses	25.55B	25.45B	28.71B	30.23B	24.46B	27.61B	27.35B	27.2B	26.77B
Interest Expense	3.09B	2.21B	1.24B	1.29B	1.45B	1.57B	1.32B	1.27B	1.19B
Selling & Marketing Expenses	n/a	3.7B	2.8B	2B	1.8B	2.3B	2.7B	3.1B	3.2B
Cost & Expenses	42.12B	55.14B	63.06B	61.05B	33.15B	37.83B	38.6B	38.44B	39.09B
Income Tax Expense	-28M	-1.11B	3.33B	1.85B	477M	1.38B	706M	-9.05B	1.12B
Shares Outstanding (Basic)	5.66B	5.64B	5.61B	5.6B	5.55B	5.57B	5.87B	5.97B	6.09B
Shares Outstanding (Diluted)	5.7B	5.71B	5.73B	5.71B	5.63B	5.67B	5.98B	6.06B	6.16B
EPS (Basic)	1.42	0.38	5.59	3.95	1.26	2.92	1.90	3.57	1.18
EPS (Diluted)	1.41	0.37	5.47	3.88	1.25	2.87	1.87	3.52	1.17
EBITDA	18.13B	9.56B	41.03B	30.79B	13.17B	18.85B	19.59B	19.84B	15.29B
EBIT	11.11B	3.27B	35.97B	25.6B	8.49B	13.06B	13.2B	13.57B	9.54B
Depreciation & Amortization	7.01B	6.29B	5.06B	5.19B	4.68B	5.79B	6.38B	6.27B	5.76B